The FDA’s Oncologic Drugs Advisory Committee narrowly voted against the approval of Zusduri, citing the lack of a completely ...

Martin Kulldorff and Robert Malone, both outspoken vaccine skeptics, have received compensation for their expert ...

Friday’s deal with fits neatly within AstraZeneca’s business development strategy of upping investments in AI and in China.

Scientists and analysts express concern that the newly appointed members—which include known anti-vaxxers—could relitigate ...

The rehired staff, who number around 460, work with the CDC’s viral disease prevention efforts and sexual health testing labs ...

After a major shareholder pushed back, Keros is returning half of its capital to investors in a move that Guggenheim analysts ...

The biopharma job market failed to turn around in May, but employers were still hiring, especially in Indiana and California, ...

The American Medical Association is also urging an “immediate reversal” of the HHS Secretary's decision to oust all 17 ...

Looking at licensing deals struck in the past 10 years, Jefferies found that many Big Pharmas do not ultimately follow ...

The loss of special government employee status for four members of the CDC’s Advisory Committee on Immunization Practices ...

Looking for a new opportunity in New Jersey? These nine companies have open roles that could be a great fit for you.

FDA Commissioner Marty Makary and CBER Director Vinay Prasad published an article in JAMA on Tuesday outlining the FDA’s ...